A Study With Central Nervous System Metastatic EGFR Mutation Positive Non-small Cell Lung Cancer
Recruiting · NCT05991193 · Observational (researchers observe without assigning treatment) · Lead sponsor: Hunan Province Tumor Hospital
View the official record on ClinicalTrials.gov →What this trial is about
This is a descriptive observational study, in which data are collected in an epidemiological fashion and prospective. This study does not intend to intervene the current medical practice of the recruited patients.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Patients must be ≥18 years.
- Provision of fully informed consent prior to any study specific procedures.
- Patient with EGFR 19Del or L858R mutation diagnosed histologically or cytologically. The mutations above may exist alone or together.
- Patients must have untreated advanced Non-Small Cell Lung Cancer (NSCLC).
- According to the RECIST 1.1 standard, the patient must have at least one measurable lesion.
Exclusion criteria
- None
Where it is running
1 location listed.
- Hunan Cancer hospital - Changsha, Hunan, China